Literature DB >> 10799008

An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones.

T R Shultz, J W Tapsall, P A White, P J Newton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799008      PMCID: PMC89829          DOI: 10.1128/AAC.44.4.1116-1116.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.

Authors: 
Journal:  Commun Dis Intell       Date:  1999-11-25

2.  Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995.

Authors:  J W Tapsall; E A Phillips; T R Shultz; C Thacker
Journal:  Sex Transm Dis       Date:  1996 Sep-Oct       Impact factor: 2.830

3.  DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae.

Authors:  T Deguchi; M Yasuda; M Asano; K Tada; H Iwata; H Komeda; T Ezaki; I Saito; Y Kawada
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  3 in total
  11 in total

1.  Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections.

Authors:  Julio A Vázquez; Luisa Arreaza; Colin Block; Ingrid Ehrhard; Stephen J Gray; Sigrid Heuberger; Steen Hoffmann; Paula Kriz; Pierre Nicolas; Per Olcen; Anna Skoczynska; Lodewijk Spanjaard; Paola Stefanelli; Muhamed-Kheir Taha; Georgina Tzanakaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 2.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

3.  Fluoroquinolones in the Treatment of Meningitis.

Authors:  Philippe Cottagnoud; Martin G. Täuber
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

4.  Meningococcal Quinolone Resistance Originated from Several Commensal Neisseria Species.

Authors:  Mingliang Chen; Chi Zhang; Xi Zhang; Min Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

5.  Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.

Authors:  Muhamed-Kheir Taha; Maria Leticia Zarantonelli; Arianna Neri; Rocío Enriquez; Julio A Vázquez; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Rifampin-resistant meningococcal disease.

Authors:  Jean Rainbow; Elizabeth Cebelinski; Joanne Bartkus; Anita Glennen; Dave Boxrud; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

7.  Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.

Authors:  Brian H Harcourt; Raydel D Anderson; Henry M Wu; Amanda C Cohn; Jessica R MacNeil; Thomas H Taylor; Xin Wang; Thomas A Clark; Nancy E Messonnier; Leonard W Mayer
Journal:  Open Forum Infect Dis       Date:  2015-08-13       Impact factor: 3.835

8.  Imported ciprofloxacin-resistant Neisseria meningitidis.

Authors:  Giuseppe Lapadula; Franco Viganò; Paolo Fortuna; Alberto Dolara; Simone Bramati; Alessandro Soria; Sergio Foresti; Andrea Gori
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

9.  Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.

Authors:  Smita Singhal; Kedar P Purnapatre; Vandana Kalia; Smita Dube; Deepti Nair; Monorama Deb; Pushpa Aggarwal; Sunil Gupta; Dilip J Upadhyay; Ashok Rattan; V Samuel Raj
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

10.  Ciprofloxacin resistance in Neisseria meningitidis, France.

Authors:  Anna Skoczynska; Jean-Michel Alonso; Muhamed-Kheir Taha
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.